These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25986825)

  • 21. Utility of a single serum testosterone measurement to determine response to topical testosterone replacement in hypogonadal men.
    Muram D; Ni X
    Curr Med Res Opin; 2016; 32(2):263-9. PubMed ID: 26549704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpectedly prolonged washout period of exogenous testosterone after discontinuation of intramuscular testosterone undecanoate depot injection (Nebido(®) or Reandron(®) ) in men with congenital hypogonadotrophic hypogonadism.
    Gan EH; Bouloux PM; Quinton R
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):947-50. PubMed ID: 26732131
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial Comment on "A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men"--New Comparative Insight on Alternative Therapies for Low Testosterone in Subfertile Men.
    Kim ED
    J Sex Med; 2015 Aug; 12(8):1770-1. PubMed ID: 26289542
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of testosterone supplementation on symptoms in men with hypogonadism.
    Ramasamy R; Wilken N; Scovell JM; Lipshultz LI
    Eur Urol; 2015 Jan; 67(1):176-177. PubMed ID: 25199721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study.
    Brock G; Heiselman D; Maggi M; Kim SW; Rodríguez Vallejo JM; Behre HM; McGettigan J; Dowsett SA; Hayes RP; Knorr J; Ni X; Kinchen K
    J Urol; 2016 Mar; 195(3):699-705. PubMed ID: 26498057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Morgentaler A
    Int J Impot Res; 2008; 20(3):331; author reply 332. PubMed ID: 18475269
    [No Abstract]   [Full Text] [Related]  

  • 28. An unusual case of vascular hypogonadism treated with clomiphene citrate and testosterone replacement.
    Tan RS; Carrejo MH; Chen D
    Andrologia; 2009 Feb; 41(1):63-5. PubMed ID: 19143734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of primary hypogonadism in men by the transdermal administration of testosterone.
    Findlay JC; Place V; Snyder PJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):369-73. PubMed ID: 2493029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.
    Ramasamy R; Scovell JM; Kovac JR; Lipshultz LI
    J Urol; 2014 Sep; 192(3):875-9. PubMed ID: 24657837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The key role of testosterone in male hypogonadism].
    Arver S; Lehtihet M
    Lakartidningen; 2009 Sep 23-29; 106(39):2460-4. PubMed ID: 19852166
    [No Abstract]   [Full Text] [Related]  

  • 32. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone therapy: many players and much controversy.
    Sigman M
    Fertil Steril; 2015 May; 103(5):1144-5. PubMed ID: 25934600
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism.
    Smith RP; Khanna A; Coward RM; Rajanahally S; Kovac JR; Gonzales MA; Lipshultz LI
    J Sex Med; 2013 Sep; 10(9):2326-33. PubMed ID: 23859250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging medication for the treatment of male hypogonadism.
    Aydogdu A; Swerdloff RS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism.
    Shabsigh A; Kang Y; Shabsign R; Gonzalez M; Liberson G; Fisch H; Goluboff E
    J Sex Med; 2005 Sep; 2(5):716-21. PubMed ID: 16422830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormone substitution with testosterone gel].
    Urologe A; 2003 Mar; 42(3):449-50. PubMed ID: 12723550
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of Long-term Post-operative Testosterone Replacement Requirement Based on the Pre-operative Tumor Volume and Testosterone Level in Pituitary Macroadenoma.
    Lee CC; Chen CM; Lee ST; Wei KC; Pai PC; Toh CH; Chuang CC
    Sci Rep; 2015 Nov; 5():16194. PubMed ID: 26537232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.